Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


David Bermudes has a total of 173 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Spore-Derived Isolates from a Single Basidiocarp of Bioluminescent Omphalotus olivascens Reveal Multifaceted Phenotypic and Physiological Variations

    by Rudy Diaz, David Bermudes

    The fungal genus Omphalotus is noted for its bioluminescence and the production of biologically active secondary metabolites. We isolated 47 fungal strains of Omphalotus olivascens germinated from spores of a single mushroom. We first noted a high degree of variation in the outward appearances in radial growth and pigmentation among the cultures. Radial growth rates fell into at least five distinct categories, with only slower-growing isolates obtained compared with the parental dikaryon. Scanning UV-vis spectroscopy of liquid-grown cultures showed variation in pigmentation in both the absorption intensity and peak absorption wavelengths, indicating that some isolates vary from the parental strain in both pigment concentration and composition. Bioluminescence intensity was observed to have isolates with both greater and lesser intensities, while the increased emission in response to caffeic acid was inversely proportional to the unstimulated output. Under UV illumination, the media of the parental strain was observed to be brightly fluorescent, which was not due to the pigment, while the isolates also varied from greater to lesser intensity and in their peak emission. At least three separate fluorescent bands were observed by gel electrophoresis from one of the cultures, while only one was observed in others. In a subset of the cultures, fluorescence intensity varied significantly in response to casamino acids. None of this subset produced an antibiotic effective against Staphylococcus aureus, and only the haploids, but not the parental heterokaryon, produced an antibiotic consistent with illudin M effective against Mycobacterium smegmatis. This same subset produced an anticancer agent that was highly potent against MDA-MB-468 breast cancer tumor cells. We interpret these variations in haploids as significant in altering Omphalotus physiology and its production of secondary metabolites, which may in turn alter their ecology and life cycle, and could be further applied to studying fungal physiologies and facilitate linking them to their genetic underpinnings.


  • Open Access

    Spore-Derived Isolates from a Single Basidiocarp of Bioluminescent Omphalotus olivascens Reveal Multifaceted Phenotypic and Physiological Variations

    by Rudy Diaz, David Bermudes

    The fungal genus Omphalotus is noted for its bioluminescence and the production of biologically active secondary metabolites. We isolated 47 fungal strains of Omphalotus olivascens germinated from spores of a single mushroom. We first noted a high degree of variation in the outward appearances in radial growth and pigmentation among the cultures. Radial growth rates fell into at least five distinct categories, with only slower growing isolates obtained compared with the parental dikaryon. Scanning UV-vis spectroscopy of liquid-grown cultures showed variation in pigmentation in both the absorption intensity and peak absorption wavelengths, indicating that some isolates vary from the parental strain in both pigment concentration and composition. Bioluminescence intensity was observed to have isolates with both greater and lesser intensities, while the increased emission in response to caffeic acid was inversely proportional to the unstimulated output. Under UV illumination the media of parental strain was observed to be brightly fluorescent, which was not due to the pigment, while the isolates also varied from greater to lesser intensity and in their peak emission. At least three separate fluorescent bands were observed by gel electrophoresis from one of the cultures, while only one was observed in others. Fluorescence intensity varied significantly in response to casamino acids. None of a subset of the cultures produced an antibiotic effective against Staphylococcus aureus, and only the haploids, but not the parental heterokaryon, produced an antibiotic consistent with illudin M effective against Mycobacterium smegmatis. This same subset all produced an anticancer agent that was highly potent against MDA-MB-468 breast cancer tumor cells. We interpret these variations in haploids as significant in altering Omphalotus physiology and its production of secondary metabolites, which may in turn alter their ecology and life cycle, and could be further applied to studying fungal physiologies and facilitate linking them to their genetic underpinnings.

  • Open Access

    Tryptophanase Expressed by Salmonella Halts Breast Cancer Cell Growth In Vitro and Inhibits Production of Immunosuppressive Kynurenine

    by Eljoie Anice Cada Hababag, Allea Cauilan, David Quintero, David Bermudes

    Tryptophan is an essential amino acid required for tumor cell growth and is also the precursor to kynurenine, an immunosuppressive molecule that plays a role in limiting anticancer immunity. Tryptophanase (TNase) is an enzyme expressed by different bacterial species that converts tryptophan into indole, pyruvate and ammonia, but is absent in the Salmonella strain VNP20009 that has been used as a therapeutic delivery vector. We cloned the Escherichia coli TNase operon tnaCAB into the VNP20009 (VNP20009-tnaCAB), and were able to detect linear production of indole over time, using Kovács reagent. In order to conduct further experiments using the whole bacteria, we added the antibiotic gentamicin to stop bacterial replication. Using a fixed number of bacteria, we found that there was no significant effect of gentamicin on stationary phase VNP20009-tnaCAB upon their ability to convert tryptophan to indole over time. We developed a procedure to extract indole from media while retaining tryptophan, and were able to measure tryptophan spectrophotometrically after exposure to gentamicin-inactivated whole bacterial cells. Using the tryptophan concentration equivalent to that present in DMEM cell culture media, a fixed number of bacteria were able to deplete 93.9% of the tryptophan in the culture media in 4 h. In VNP20009-tnaCAB depleted tissue culture media, MDA-MB-468 triple negative breast cancer cells were unable to divide, while those treated with media exposed only to VNP20009 continued cell division. Re-addition of tryptophan to conditioned culture media restored tumor cell growth. Treatment of tumor cells with molar equivalents of the TNase products indole, pyruvate and ammonia only caused a slight increase in tumor cell growth. Using an ELISA assay, we confirmed that TNase depletion of tryptophan also limits the production of immunosuppressive kynurenine in IFNγ-stimulated MDA-MB-468 cancer cells. Our results demonstrate that Salmonella VNP20009 expressing TNase has improved potential to stop tumor cell growth and reverse immunosuppression.


  • Co-expression of a Chimeric Protease Inhibitor Secreted Salmonella Protects Therapeutic Proteins from Proteolytic Degradation.

    by David Quintero, Jamie Carrafa, Lena Vincent, Hee Jong Lee, James Wohlschlegel, David Bermudes

    Sunflower trypsin inhibitor (SFTI) is a 14-amino-acid bicyclic peptide that contains a single internal disulfide bond. We initially constructed chimeras of SFTI with N-terminal secretion signals from the Escherichia coli OmpA and Pseudomonas aeruginosa ToxA, but only detected small amounts of protease inhibition resulting from these constructs. A substantially higher degree of protease inhibition was detected from a C-terminal SFTI fusion with E. coli YebF, which radiated more than a centimeter from an individual colony of E. coli using a culture-based inhibitor assay. Inhibitory activity was further improved in YebF-SFTI fusions by the addition of a trypsin cleavage signal immediately upstream of SFTI, and resulted in production of a 14-amino-acid, disulfide-bonded SFTI free in the culture supernatant. To assess the potential of the secreted SFTI to protect the ability of a cytotoxic protein to kill tumor cells, we utilized a tumor-selective form of the Pseudomonas ToxA (OTG-PE38K) alone and expressed as a polycistronic construct with YebF-SFTI in the tumor-targeted Salmonella VNP20009. When we assessed the ability of toxin-containing culture supernatants to kill MDA-MB-468 breast cancer cells, the untreated OTG-PE38K was able to eliminate all detectable tumor cells, while pretreatment with trypsin resulted in the complete loss of anti-cancer cytotoxicity. However, when OTG-PE38K was co-expressed with YebF-SFTI, cytotoxicity was completely retained in the presence of trypsin. These data demonstrate SFTI chimeras are secreted in a functional form and that co-expression of protease inhibitors with therapeutic proteins by tumor-targeted bacteria has the potential to enhance the activity of therapeutic proteins by suppressing their degradation within a proteolytic environment.


  • Open Access

    EGFR‐targeted Chimeras of Pseudomonas ToxA released into the extracellular milieu by attenuated Salmonella selectively kill tumor cells

    by David Quintero, Jamie Carrafa, Lena Vincent, David Bermudes

    Tumor‐targeted Salmonella VNP20009 preferentially replicate within tumor tissue and partially suppress tumor growth in murine tumor models. These Salmonella have the ability to locally induce apoptosis when they are in direct contact with cancer cells but they lack significant bystander killing, which may correlate with their overall lack of antitumor activity in human clinical studies. In order to compensate for this deficiency without enhancing overall toxicity, we engineered the bacteria to express epidermal growth factor receptor (EGFR)‐targeted cytotoxic proteins that are released into the extracellular milieu. In this study, we demonstrate the ability of the Salmonella strain VNP20009 to produce three different forms of the Pseudomonas exotoxin A (ToxA) chimeric with a tumor growth factor alpha (TGFα) which results in its producing culture supernatants that are cytotoxic and induce apoptosis in EGFR positive cancer cells as measured by the tetrazolium dye reduction, and Rhodamine 123 and JC‐10 mitochondrial depolarization assays. In addition, exchange of the ToxA REDLK endoplasmic reticulum retention signal for KDEL and co‐expression of the ColE3 lysis protein resulted in an overall increased cytotoxicity compared to the wild type toxin. This approach has the potential to significantly enhance the antitumor activity of VNP20009 while maintaining its previously established safety profile. Biotechnol. Bioeng. 2016;113: 2698–2711. © 2016 The Authors. Biotechnology and Bioengineering published by Wiley Periodicals, Inc.


  • Isolation and Analysis of Suppressor Mutations in Tumor-Targeted msbB Salmonella

    by K. Brooks Low, Sean R. Murray, John Pawelek, David Bermudes

    Tumor-targeted Salmonella offers a promising approach to the delivery of therapeutics for the treatment of cancer. The Salmonella strains used, however, must be stably attenuated in order to provide sufficient safety for administration. Approaches to the generation of attenuated Salmonella strains have included deletion of the msbB gene that is responsible for addition of the terminal myristol group to lipid A. In the absence of myristoylation, lipid A is no longer capable of inducing septic shock, resulting in a significant enhancement in safety. However, msbB Salmonella strains also exhibit an unusual set of additional physiological characteristics, including sensitivities to NaCl, EGTA, deoxycholate, polymyxin, and CO2. Suppressor mutations that compensate for these sensitivities include somA, Suwwan, pmrA C , and zwf. We describe here methods for isolation of strains with compensatory mutations that suppress these types of sensitivities and techniques for determining their underlying genetic changes and analysis of their effects in murine tumor models.


  • Leukemia-selective uptake and cytotoxicity of CPX-351, a synergistic fixed-ratio cytarabine:daunorubicin formulation, in bone marrow xenografts

    by Wah-Seng Lim, Paul G. Tardi, Nancy Dos Santos, Xiaowei Xie, Mannie Fan, Barry D. Liboiron, Xiaoping Huang, Troy O. Harasym, David Bermudes, Lawrence D. Mayer